MedTrace Logo

Effects of Aerobic Exercises and Yoga on Premenstrual Syndrome

NCT05834127 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2023-12-27

No results posted yet for this study

Summary

Sign and symptoms including mood swings, sensitive breasts, food cravings, exhaustion, irritability, pain and sadness. The physical and emotional changes you go through with premenstrual syndrome can range from hardly perceptible to severe. Some people's physical discomfort and emotional stress are so severe that it interferes with their daily life. Regardless of the severity of the symptoms, most women's signs and symptoms go away four days following the start of their menstrual cycle. In this study the effects of aerobic exercises and Yoga on premenstrual syndrome population will be analyzed. This study will be a randomized clinical trial which will incorporate two different interventions. Aerobic exercises and yoga would be administered to the females. 32 patients will randomly divided into two groups. Assessment will be done by using PMS scale and visual analogue scale. The goal of this study to compare the effects of aerobic exercises and yoga on premenstrual syndrome.

Conditions

  • Premenstrual Syndrome
  • Pain

Interventions

OTHER

Aerobic exercise

Group A will receive aerobic exercise in the form of warm up and cool down (both for 5 min) * Treadmill (30 min) based on Target Heart Rate (calculated using Karvina formula at 60%-70% of heart rate reserve). * Treatment will be given 3 times a week for 1 month

OTHER

Yoga Exercises

Group B will receive yoga movements for 40 min, 3 times a week for 1 month. * They will be given yoga movements, including 10 min of Kapalbharti Pranayama which includes automatic inhalation with short and forceful exhalations. * 20 min of yoga movements (Cat-cow pose, Child's pose, Plank pose, Cobra pose - each for 5 min). * 10 min of meditation/relaxation in Savasana pose

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Sabiha Arshad, M.phil · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-20
Primary Completion
2023-07-30
Completion
2023-08-01

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05834127 on ClinicalTrials.gov